Aridis pharmaceuticals says license agreement with the serum institute of india

Aridis pharmaceuticals executes license agreement with the serum institute of india, ltd. for exclusive rights to products and utilization of mabigx® platform technology.aridis pharmaceuticals - under deal, co to receive remaining upfront cash payment of $10 million, in addition to $5 million that was initially received.
ARDS Ratings Summary
ARDS Quant Ranking